• Autoimmune disorders increase risk of cardiovascular disease

    Saturday August 27th 2022

  • Biocartis obtains ISO 27001 certification for information security management

    Thursday August 25th 2022

  • Alexandra Clyde appointed to Sequana Medical Board of Directors

    Thursday August 25th 2022

  • KU Leuven spin-off AstriVax raises € 30 million to build vaccine platform

    Thursday August 25th 2022

  • mRNA leading expert Kenneth Chien and Novalis LifeSciences’ Marijn Dekkers investing in EUR 39M Series B2 financing of mRNA technology platform company eTheRNA

    Tuesday August 23rd 2022

  • argenx announces European Commission approval of VYVGART™ (efgartigimod alfa-fcab) for the treatment of generalized myasthenia gravis

    Thursday August 11th 2022

  • Bone Therapeutics to broaden and derisk therapeutic portfolio by acquiring majority participation in Medsenic

    Wednesday August 10th 2022

  • Mayne Pharma and Mithra announce FDA approval of HALOETTE®, a generic version of NUVARING®

    Monday August 8th 2022

  • Your news here?

  • S-Biomedic welcomes Pascal Yvon to lead its B2B commercial activities

    Tuesday August 2nd 2022

  • Celyad Oncology announces FDA lifts clinical hold of CYAD-101-002 Phase 1b trial

    Monday August 1st 2022

  • NEXTSTELLIS® oral contraceptive now available in Australia

    Tuesday July 26th 2022


Strategic Partners